Can a light beam clear stubborn blackheads?

NCT ID NCT06909344

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 18, 2026 · Last updated Aug 19, 2026 · Updated 1 time

Summary

This trial tests whether a 577-nm diode laser can safely reduce non-inflammatory acne, such as blackheads and whiteheads. Half of each participant's face receives laser treatment, while the other half serves as an untreated control. The study includes adults aged 18-40 with at least 10 comedonal lesions on each side of the face. The main goal is to see if the laser decreases the number of comedones.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
577-nm diode laser treatment
What this could lead to
If effective, this laser could offer a non-invasive, drug-free option for reducing comedonal acne.
What could go wrong
This is a small, early-stage trial, and results may not apply to all acne types. Possible side effects include redness or irritation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

50 people

The number who actually took part.

Started

Mar 2025

Finished

Feb 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 40 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients with acne comedones * Patients' ages range from 18-40 years. * Minimum 10 comedonal lesions on both half of the face Exclusion Criteria: * Patients with systemic disease interfere with healing. * Patients with Photosensitivity. * Pregnant or lactating females. * Previous topical, systemic, laser, surgical treatment and comedogenic drugs in the last 3 months. * Skin cancer or suspicious lesions.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acne are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acne Acne Vulgaris

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Azhar Assuit university hospital

    Asyut, Assuit, 71511, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.